Skip to content

Clinical trials

Inflammation trials in Pakistan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Country / region: Pakistan Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20181
20191
20202
20211
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Khyber Medical University Peshawar3
Aga Khan University1
Johns Hopkins Bloomberg School of Public Health1
Nishtar Medical University1
Pakistan Institute of Living and Learning1
Population Health Research Institute1
Prof. Dr. Fridoon Jawad Ahmad1
University of Agriculture, Peshawar1
University of Michigan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation11
Diabetes Mellitus2
Insulin Resistance2
Anxiety Disorders1
Atrial Fibrillation1
Atrial Flutter1
COVID-191
Conjunctivitis1
Coronavirus Infections1
Diabetes, Gestational1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.